Ticker Details
Arcus Biosciences, Inc.
IPO Date:	March 12, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$3.77B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.66 | 3.35%
Avg Daily Range (30 D):	$0.83 | 3.22%
Avg Daily Range (90 D):	$0.79 | 3.30%

Institutional Daily Volume
Avg Daily Volume:	.57M
Avg Daily Volume (30 D):	1.13M
Avg Daily Volume (90 D):	1M

Trade Size
Avg Trade Size (Sh.):	76
Avg Trade Size (Sh.) (30 D):	68
Avg Trade Size (Sh.) (90 D):	67

Institutional Trades
Total Institutional Trades:	3,110
Avg Institutional Trade:	$2.45M
Avg Institutional Trade (30 D):	$3.32M
Avg Institutional Trade (90 D):	$2.97M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.12M
Avg Closing Trade (30 D):	$8.07M
Avg Closing Trade (90 D):	$5.92M
Avg Closing Volume:	146.84K

News

Dec 2, 2024 @ 3:18 PM Biotech Advances Drive Cancer Research as Global R... Source: Prnewswire

Aug 23, 2024 @ 3:47 PM Retinoblastoma Treatment Market to Surpass $2 Bill... Source: Researchandmarkets.Com

Jul 8, 2024 @ 9:00 PM Cracking The Code: Understanding Analyst Reviews F... Source: Benzinga Insights, Benzinga Staff Writer

Jun 7, 2024 @ 2:55 PM Is The Options Market Predicting a Spike In Arcus ... Source: Zacks Equity Research

Jun 3, 2024 @ 5:59 PM Gilead (GILD), RCUS Announce Data From Colorectal ... Source: Zacks Equity Research

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-3.19	$-1.02	$-.9
Diluted EPS	$-3.19	$-1.02	$-.9
Revenue	$236M	$17M	$33M
Gross Profit
Net Income / Loss	$-369M	$-128M	$-106M
Operating Income / Loss	$-398M	$-134M	$-114M
Cost of Revenue
Net Cash Flow	$9M	$-21M	$-16M
PE Ratio